Actinogen Medical Limited Stock Performance
On a scale of 0 to 100, Actinogen Medical holds a performance score of 5. The firm shows a Beta (market volatility) of 1.59, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Actinogen Medical will likely underperform. Please check Actinogen Medical's jensen alpha, kurtosis, as well as the relationship between the Kurtosis and day typical price , to make a quick decision on whether Actinogen Medical's price patterns will revert.
Risk-Adjusted Performance
Mild
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Actinogen Medical Limited are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile technical and fundamental indicators, Actinogen Medical reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 13.4 M | |
| Total Cashflows From Investing Activities | -2937.00 |
Actinogen |
Actinogen Medical Relative Risk vs. Return Landscape
If you would invest 2.50 in Actinogen Medical Limited on November 12, 2025 and sell it today you would earn a total of 0.61 from holding Actinogen Medical Limited or generate 24.4% return on investment over 90 days. Actinogen Medical Limited is currently producing 0.5992% returns and takes up 8.1046% volatility of returns over 90 trading days. Put another way, 72% of traded pink sheets are less volatile than Actinogen, and 88% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Actinogen Medical Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Actinogen Medical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Actinogen Medical can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Actinogen Medical is way too risky over 90 days horizon | |
| Actinogen Medical has some characteristics of a very speculative penny stock | |
| Actinogen Medical appears to be risky and price may revert if volatility continues | |
| Actinogen Medical has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 3.64 M. Net Loss for the year was (9.5 M) with profit before overhead, payroll, taxes, and interest of 3.64 M. | |
| Actinogen Medical generates negative cash flow from operations | |
| About 20.0% of the company shares are held by company insiders |
Actinogen Medical Fundamentals Growth
Actinogen Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Actinogen Medical, and Actinogen Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Actinogen Pink Sheet performance.
| Return On Equity | -0.48 | |||
| Return On Asset | -0.29 | |||
| Profit Margin | (2.61) % | |||
| Operating Margin | (2.62) % | |||
| Current Valuation | 125.91 M | |||
| Shares Outstanding | 1.81 B | |||
| Price To Book | 12.26 X | |||
| Price To Sales | 49.62 X | |||
| Revenue | 3.64 M | |||
| EBITDA | (9.08 M) | |||
| Debt To Equity | 0.04 % | |||
| Book Value Per Share | 0.01 X | |||
| Cash Flow From Operations | (9.52 M) | |||
| Earnings Per Share | (0) X | |||
| Total Asset | 23.31 M | |||
About Actinogen Medical Performance
By analyzing Actinogen Medical's fundamental ratios, stakeholders can gain valuable insights into Actinogen Medical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Actinogen Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Actinogen Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Actinogen Medical Limited, a biotechnology company, develops therapies for cognitive impairment associated with chronic neurological, psychiatric, and metabolic diseases in Australia. Actinogen Medical Limited was incorporated in 1999 and is headquartered in Sydney, Australia. Actinogen Med operates under Biotechnology classification in the United States and is traded on OTC Exchange.Things to note about Actinogen Medical performance evaluation
Checking the ongoing alerts about Actinogen Medical for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Actinogen Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Actinogen Medical is way too risky over 90 days horizon | |
| Actinogen Medical has some characteristics of a very speculative penny stock | |
| Actinogen Medical appears to be risky and price may revert if volatility continues | |
| Actinogen Medical has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 3.64 M. Net Loss for the year was (9.5 M) with profit before overhead, payroll, taxes, and interest of 3.64 M. | |
| Actinogen Medical generates negative cash flow from operations | |
| About 20.0% of the company shares are held by company insiders |
- Analyzing Actinogen Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Actinogen Medical's stock is overvalued or undervalued compared to its peers.
- Examining Actinogen Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Actinogen Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Actinogen Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Actinogen Medical's pink sheet. These opinions can provide insight into Actinogen Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Actinogen Pink Sheet analysis
When running Actinogen Medical's price analysis, check to measure Actinogen Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Actinogen Medical is operating at the current time. Most of Actinogen Medical's value examination focuses on studying past and present price action to predict the probability of Actinogen Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Actinogen Medical's price. Additionally, you may evaluate how the addition of Actinogen Medical to your portfolios can decrease your overall portfolio volatility.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |